156 related articles for article (PubMed ID: 33676014)
1. Does moderate intensity impact exercise and non-impact exercise induce acute changes in collagen biochemical markers related to osteoarthritis? - An exploratory randomized cross-over trial.
Bjerre-Bastos JJ; Nielsen HB; Andersen JR; Karsdal M; Bay-Jensen AC; Boesen M; Mackey AL; Byrjalsen I; Bihlet AR
Osteoarthritis Cartilage; 2021 Jul; 29(7):986-994. PubMed ID: 33676014
[TBL] [Abstract][Full Text] [Related]
2. A biomarker perspective on the acute effect of exercise with and without impact on joint tissue turnover: an exploratory randomized cross-over study.
Bjerre-Bastos JJ; Nielsen HB; Andersen JR; Karsdal M; Boesen M; Mackey AL; Byrjalsen I; Thudium CS; Bihlet AR
Eur J Appl Physiol; 2021 Oct; 121(10):2799-2809. PubMed ID: 34156534
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Weight-bearing Exercise, Non-Weight-bearing Exercise, and Cardiovascular Stress on Biochemical Markers of Cartilage Turnover in Patients With Mild to Moderate Knee Osteoarthritis: A Sequential, Cross-Over, Clinical Study.
Bjerre-Bastos JJ; Sejersen C; Nielsen HB; Boesen M; Secher NH; Distajo G; Flood V; Henrotin Y; Uebelhoer M; Krustrup P; Kitchen CC; Thudium CS; Andersen JR; Bihlet AR
Cartilage; 2024 Jun; ():19476035241258170. PubMed ID: 38853398
[TBL] [Abstract][Full Text] [Related]
4. A low cartilage formation and repair endotype predicts radiographic progression of symptomatic knee osteoarthritis.
Luo Y; Samuels J; Krasnokutsky S; Byrjalsen I; Kraus VB; He Y; Karsdal MA; Abramson SB; Attur M; Bay-Jensen AC
J Orthop Traumatol; 2021 Mar; 22(1):10. PubMed ID: 33687578
[TBL] [Abstract][Full Text] [Related]
5. Biochemical Response to a Moderate Running Bout in Participants With or Without a History of Acute Knee Injury.
Cattano NM; Driban JB; Barbe MF; Tierney RT; Amin M; Sitler MR
J Athl Train; 2017 Jun; 52(6):567-574. PubMed ID: 27186917
[TBL] [Abstract][Full Text] [Related]
6. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
[TBL] [Abstract][Full Text] [Related]
7. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.
Cibere J; Thorne A; Kopec JA; Singer J; Canvin J; Robinson DB; Pope J; Hong P; Grant E; Lobanok T; Ionescu M; Poole AR; Esdaile JM
J Rheumatol; 2005 May; 32(5):896-902. PubMed ID: 15868627
[TBL] [Abstract][Full Text] [Related]
8. Cartilage oligomeric protein, matrix metalloproteinase-3, and Coll2-1 as serum biomarkers in knee osteoarthritis: a cross-sectional study.
Georgiev T; Ivanova M; Kopchev A; Velikova T; Miloshov A; Kurteva E; Yuzeir K; Penkov M; Kabakchieva P; Rashkov R; Stoilov R
Rheumatol Int; 2018 May; 38(5):821-830. PubMed ID: 29164307
[TBL] [Abstract][Full Text] [Related]
9. Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study.
Cibere J; Zhang H; Garnero P; Poole AR; Lobanok T; Saxne T; Kraus VB; Way A; Thorne A; Wong H; Singer J; Kopec J; Guermazi A; Peterfy C; Nicolaou S; Munk PL; Esdaile JM
Arthritis Rheum; 2009 May; 60(5):1372-80. PubMed ID: 19404937
[TBL] [Abstract][Full Text] [Related]
10. Cartilage oligomeric matrix protein, C-terminal cross-linking telopeptide of type II collagen, and matrix metalloproteinase-3 as biomarkers for knee and hip osteoarthritis (OA) diagnosis: a systematic review and meta-analysis.
Hao HQ; Zhang JF; He QQ; Wang Z
Osteoarthritis Cartilage; 2019 May; 27(5):726-736. PubMed ID: 30391538
[TBL] [Abstract][Full Text] [Related]
11. Relationships amongst osteoarthritis biomarkers, dynamic knee joint load, and exercise: results from a randomized controlled pilot study.
Hunt MA; Pollock CL; Kraus VB; Saxne T; Peters S; Huebner JL; Sayre EC; Cibere J
BMC Musculoskelet Disord; 2013 Mar; 14():115. PubMed ID: 23530976
[TBL] [Abstract][Full Text] [Related]
12. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover.
Siebuhr AS; Petersen KK; Arendt-Nielsen L; Egsgaard LL; Eskehave T; Christiansen C; Simonsen O; Hoeck HC; Karsdal MA; Bay-Jensen AC
Osteoarthritis Cartilage; 2014 Jan; 22(1):44-50. PubMed ID: 24216059
[TBL] [Abstract][Full Text] [Related]
14. A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage Formation.
Luo Y; He Y; Reker D; Gudmann NS; Henriksen K; Simonsen O; Ladel C; Michaelis M; Mobasheri A; Karsdal M; Bay-Jensen AC
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404167
[TBL] [Abstract][Full Text] [Related]
15. Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis.
Valdes AM; Meulenbelt I; Chassaing E; Arden NK; Bierma-Zeinstra S; Hart D; Hofman A; Karsdal M; Kloppenburg M; Kroon HM; Slagboom EP; Spector TD; Uitterlinden AG; van Meurs JB; Bay-Jensen AC
Osteoarthritis Cartilage; 2014 May; 22(5):683-9. PubMed ID: 24576742
[TBL] [Abstract][Full Text] [Related]
16. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.
Bruyere O; Collette J; Kothari M; Zaim S; White D; Genant H; Peterfy C; Burlet N; Ethgen D; Montague T; Dabrowski C; Reginster JY
Ann Rheum Dis; 2006 Aug; 65(8):1050-4. PubMed ID: 16396978
[TBL] [Abstract][Full Text] [Related]
17. Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey.
Tanishi N; Yamagiwa H; Hayami T; Mera H; Koga Y; Omori G; Endo N
J Bone Miner Metab; 2009; 27(5):605-12. PubMed ID: 19381754
[TBL] [Abstract][Full Text] [Related]
18. The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and 6-year follow-up study in middle-aged subjects.
Kumm J; Tamm A; Lintrop M; Tamm A
Rheumatol Int; 2013 Apr; 33(4):903-11. PubMed ID: 22821260
[TBL] [Abstract][Full Text] [Related]
19. Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis.
Bihlet AR; Byrjalsen I; Bay-Jensen AC; Andersen JR; Christiansen C; Riis BJ; Karsdal MA
Arthritis Res Ther; 2019 Sep; 21(1):203. PubMed ID: 31481084
[TBL] [Abstract][Full Text] [Related]
20. Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial.
Henrotin Y; Berenbaum F; Chevalier X; Marty M; Richette P; Rannou F
BMC Musculoskelet Disord; 2017 May; 18(1):222. PubMed ID: 28549430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
